Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ovarian Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    November 2022
  1. WANG T, Liu J, Huang X, Zhang C, et al
    Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  2. LI J, Li D, Zhang W
    [Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    June 2022
  3. HE M, Sun HG, Hao JY, Li YL, et al
    [Corrigendum) RNA interferencemediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycininduced apoptosis dependent on JNK activation.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    May 2022
  4. ZHANG Q, Ding J, Wang Y, He L, et al
    Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review).
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    April 2022
  5. ZHOU X, Zhao F, Wang ZN, Song YX, et al
    [Corrigendum] Altered expression of miR152 and miR148a in ovarian cancer is related to cell proliferation.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  6. YANG L, Xie HJ, Li YY, Wang X, et al
    Molecular mechanisms of platinumbased chemotherapy resistance in ovarian cancer (Review).
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    March 2022
  7. PARK SA, Kim LK, Park HM, Kim HJ, et al
    Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    October 2021
  8. CHENG L, Zhang D, Yan W
    Ultrasoundtargeted microbubble destructionmediated overexpression of Sirtuin 3 inhibits the progression of ovarian cancer.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  9. LI H, Liu Y, Wang Y, Zhao X, et al
    Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  10. CUI S, Li F
    RHPN1AS1 promotes ovarian carcinogenesis by sponging miR68845p thus releasing TOP2A mRNA.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    September 2021
  11. PAN Y, Zhang L, Zhang X, Liu R, et al
    [Retracted] Synergistic effects of eukaryotic coexpression plasmidbased STAT3specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    August 2021
  12. WEN J, Han S, Cui M, Wang Y, et al
    [Retracted] Long noncoding RNA MCM3APAS1 drives ovarian cancer progression via the microRNA1433p/TAK1 axis.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    June 2021
  13. CUI S, Li C
    RHPN1AS1 promotes ovarian carcinogenesis by sponging miR4855p and releasing TPX2 mRNA.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    May 2021
  14. ZHONG Y, Le F, Cheng J, Luo C, et al
    Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatinresistant SKOV3/DDP ovarian cancer cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  15. LIANG X, Ju J
    Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  16. LI M, Zhang S, Ma Y, Yang Y, et al
    Role of hsamiR105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  17. FREUND E, Miebach L, Stope MB, Bekeschus S, et al
    Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    April 2021
  18. CAO S, Chen C, Xue J, Huang Y, et al
    [Corrigendum] Silencing of type Igamma phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available


  19. LEE SY, Kwon J, Lee KA
    Bcl2l10 induces metabolic alterations in ovarian cancer cells by regulating the TCA cycle enzymes SDHD and IDH1.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  20. CHEN J, Chen H, Pan L
    SIRT1 and gynecological malignancies (Review).
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    December 2020
  21. WEI L, He Y, Bi S, Li X, et al
    miRNA199b3p suppresses growth and progression of ovarian cancer via the CHK1/Ecadherin/EMT signaling pathway by targeting ZEB1.
    Oncol Rep. 2020 Dec 11. doi: 10.3892/or.2020.7895.
    PubMed     Abstract available


  22. AN Q, Liu T, Wang MY, Yang YJ, et al
    KRT7 promotes epithelialmesenchymal transition in ovarian cancer via the TGFbeta/Smad2/3 signaling pathway.
    Oncol Rep. 2020 Dec 8. doi: 10.3892/or.2020.7886.
    PubMed     Abstract available


  23. ZHAO L, Liu Z, Deng X, Wang J, et al
    Polyphyllin VII induces mitochondrial apoptosis by regulating the PP2A/AKT/DRP1 signaling axis in human ovarian cancer.
    Oncol Rep. 2020 Dec 2. doi: 10.3892/or.2020.7879.
    PubMed     Abstract available


  24. BRUM MCM, Dos Santos Guimaraes I, Ferreira LB, Rangel LBA, et al
    Osteopontinc isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
    Oncol Rep. 2020 Dec 1. doi: 10.3892/or.2020.7877.
    PubMed     Abstract available


    November 2020
  25. LEE DW, Lee W, Kwon M, Lee HN, et al
    Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells.
    Oncol Rep. 2020 Nov 11. doi: 10.3892/or.2020.7845.
    PubMed     Abstract available


  26. ZHAO M, Ji H, Fu Q, Cheng Q, et al
    MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro.
    Oncol Rep. 2020 Nov 10. doi: 10.3892/or.2020.7844.
    PubMed     Abstract available


    October 2020
  27. ZHANG H, Hu L, Cheng M, Wang Q, et al
    The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
    Oncol Rep. 2020 Oct 9. doi: 10.3892/or.2020.7798.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: